Login / Signup

Evaluation of the Ginsburg Scheme: Where Is Significant Prostate Cancer Missed?

August SigleCordula A JilgTimur H KuruNadine BinderJakob MichaelisMarkus GrabbertWolfgang Schultze-SeemannArkadiusz MiernikChristian GratzkeMatthias BenndorfRodrigo Suarez-Ibarrola
Published in: Cancers (2021)
This is the first study to analyze the distribution of sPCa missed by the GBS. GBS misses sPCa in few men only, with the majority localized in the anterior region. Adding blind sectors to GBS defined a new sector map of the prostate suited for reporting histopathological biopsy results.
Keyphrases
  • prostate cancer
  • radical prostatectomy
  • ultrasound guided
  • adverse drug